Is a single day patient friendly methyl aminolevulinate photodynamic therapy illumination scheme for superficial basal cell carcinoma feasible? A randomized multicenter pilot trial

References

• Flohil SC, de Vries E, Neumann HA, et al. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol. 2011;91:24–30.
   PubMed Web of Science ®Google Scholar
• Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012;166:1069–1080.
   PubMed Web of Science ®Google Scholar
• Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48:425–429.
   PubMed Web of Science ®Google Scholar
• Arits AH, Schlangen MH, Nelemans PJ, et al. Trends in the incidence of basal cell carcinoma by histopathological subtype. J Eur Acad Dermatol Venereol. 2011;25:565–569.
   PubMed Web of Science ®Google Scholar
• Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56:125–143.
   PubMed Web of Science ®Google Scholar
• Morton C, Szeimies RM, Sidoroff A, et al. European Dermatology Forum Guidelines on topical photodynamic therapy. Eur J Dermatol. 2015;25:296–311.
   PubMed Web of Science ®Google Scholar
• Morton CA, Szeimies RM, Sidoroff A, et al. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27:536–544.
   PubMed Web of Science ®Google Scholar
• Trakatelli M, Morton C, Nagore E, et al. Update of the European guidelines for basal cell carcinoma management. Eur J Dermatol. 2014;24:312–329.
   PubMed Web of Science ®Google Scholar
• Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159:1245–1266.
   PubMed Web of Science ®Google Scholar
• Arits AH, Spoorenberg E, Mosterd K, et al. Cost-effectiveness of topical Imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma. Br J Dermatol. 2014;171:1501–1507.
   PubMed Web of Science ®Google Scholar
• de Haas ER, Kruijt B, Sterenborg HJ, et al. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy. J Invest Dermatol. 2006;126:2679–2686.
   PubMed Web of Science ®Google Scholar
• Star WM, van’t Veen AJ, Robinson DJ, et al. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up. Acta Derm Venereol. 2006;86:412–417.
   PubMed Web of Science ®Google Scholar
• de Vijlder HC, Sterenborg HJ, Neumann HA, et al. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. Acta Derm Venereol. 2012;92:641–647.
   PubMed Web of Science ®Google Scholar
• van der Veen N, van Leengoed HL, Star WM. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer. 1994;70:867–872.
   PubMed Web of Science ®Google Scholar
• Van der Veen N, De Bruijn HS, Star WM. Photobleaching during and re-appearance after photodynamic therapy of topical ALA-induced fluorescence in UVB-treated mouse skin. Int J Cancer. 1997;72:110–118.
   PubMed Web of Science ®Google Scholar
• Robinson DJ, de Bruijn HS, de Wolf WJ, et al. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect. Photochem Photobiol. 2000;72:794–802.
   PubMed Web of Science ®Google Scholar
• de Bruijn HS, de Haas ER, Hebeda KM, et al. Light fractionation does not enhance the efficacy of methyl 5-aminolevulinate mediated photodynamic therapy in normal mouse skin. Photochem Photobiol Sci. 2007;6:1325–1331.
   PubMed Web of Science ®Google Scholar
• Robinson DJ, de Bruijn HS, Star WM, et al. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin. Photochem Photobiol. 2003;77:319–323.
   PubMed Web of Science ®Google Scholar
• de Bruijn HS, van der Ploeg-van den Heuvel A, Sterenborg HJ, et al. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval. J Photochem Photobiol B. 2006;85:184–190.
   PubMed Web of Science ®Google Scholar
• Angell-Petersen E, Sorensen R, Warloe T, et al. Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol. 2006;126:265–271.
   PubMed Web of Science ®Google Scholar
• Peng Q, Moan J, Warloe T, et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol Biol B. 1996;34:95–96.
   PubMed Web of Science ®Google Scholar
• Fritsch C, Homey B, Stahl W, et al. Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photchem Photbio. 1998;68:218.
   PubMed Web of Science ®Google Scholar
• Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015;88:167–179.
   PubMedGoogle Scholar
• Kelleners-Smeets NW dHEBR, Ingels KJAO, Corten EML, et al. Evidence based richtlijn basaalcelcarcinoom (modulaire update 2014). 2014.
   Google Scholar
• Arits AH, Mosterd K, Essers BA, et al. Photodynamic therapy versus topical Imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14:647–654.
   PubMed Web of Science ®Google Scholar
• Szeimies RM, Ibbotson S, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008;22:1302–1311.
   PubMed Web of Science ®Google Scholar
• Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol. 2008;18:547–553.
   PubMed Web of Science ®Google Scholar
• Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy – practical pearls. J Dermatol Treat. 2003;14:23–26.
   PubMedGoogle Scholar
• Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159:35–48.
   PubMed Web of Science ®Google Scholar
• Fantini F, Greco A, Del Giovane C, et al. Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J Eur Acad Dermatol Venereol. 2011;25:896–901.
   PubMed Web of Science ®Google Scholar
• Rhodes LE, de Rie MA, Leifsdottir R, et al. Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma. Arch Dermatol. 2007;143:1131–1136.
   PubMed Web of Science ®Google Scholar
• Hoogedoorn L, Hendriks JC, Knuiman GJ, et al. Treatment failure in superficial basal cell carcinoma following treatment with photodynamic therapy: is this a result of underdiagnosis? J Eur Acad Dermatol Venereol. 2017;31:e50–ee2.
   PubMed Web of Science ®Google Scholar
• Nguyen KP, Knuiman GJ, van Erp PE, et al. Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes. Am Acad Dermatol. 2017;76:351–353.e3.
   PubMed Web of Science ®Google Scholar
• Roozeboom MH, Arits AH, Mosterd K, et al. Three-year follow-up results of photodynamic therapy vs. Imiquimod vs. fluorouracil for treatment of superficial basal cell carcinoma: a single-blind, noninferiority, randomized controlled trial. J Invest Dermatol. 2016;136:1568–1574.
   PubMed Web of Science ®Google Scholar
• Longo C, Lallas A, Kyrgidis A, et al. Classifying distinct basal cell carcinoma subtype by means of dermatoscopy and reflectance confocal microscopy. J Am Acad Dermatol. 2014;71:716–724.e1.
   PubMed Web of Science ®Google Scholar
• Peppelman M, Wolberink EA, Blokx WA, et al. In vivo diagnosis of basal cell carcinoma subtype by reflectance confocal microscopy. Dermatology (Basel). 2013;227:255–262.
   PubMed Web of Science ®Google Scholar